133 related articles for article (PubMed ID: 16601476)
1. First-trimester screening: lessons from clinical trials and implementation.
Koos BJ
Curr Opin Obstet Gynecol; 2006 Apr; 18(2):152-5. PubMed ID: 16601476
[No Abstract] [Full Text] [Related]
2. Antenatal screening - the first and second trimester.
Bonacquisto L
Aust Fam Physician; 2011 Oct; 40(10):785-7. PubMed ID: 22003480
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
[TBL] [Abstract][Full Text] [Related]
4. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
[TBL] [Abstract][Full Text] [Related]
5. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
6. Role of second-trimester ultrasound in screening for Down syndrome.
Cuckle H; Maymon R
Ultrasound Obstet Gynecol; 2013 Mar; 41(3):241-4. PubMed ID: 23460191
[No Abstract] [Full Text] [Related]
7. Nuchal translucency measurement in first trimester Down syndrome screening.
Scott A
Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
[TBL] [Abstract][Full Text] [Related]
8. Nuchal translucency measurement and second-trimester biochemical screening for Down's syndrome.
Frohlich EP
Ultrasound Obstet Gynecol; 1997 Sep; 10(3):221-2. PubMed ID: 9339533
[No Abstract] [Full Text] [Related]
9. DISQ 8: Management of patients with an increased first-trimester Down syndrome screening risk and normal fetal karyotype.
Alfirevic Z
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):232. PubMed ID: 18254160
[No Abstract] [Full Text] [Related]
10. First-trimester Ultrasound and Aneuploidy Screening in Multifetal Pregnancies.
Hirshberg A; Dugoff L
Clin Obstet Gynecol; 2015 Sep; 58(3):559-73. PubMed ID: 26133496
[TBL] [Abstract][Full Text] [Related]
11. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
12. Nuchal translucency-based Down syndrome screening: barriers to implementation.
Malone FD
Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Down syndrome screening strategies.
Wenstrom KD
Semin Perinatol; 2005 Aug; 29(4):219-24. PubMed ID: 16104672
[TBL] [Abstract][Full Text] [Related]
14. [Down syndrome screening by ultrasound].
Rozenberg P
Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
[TBL] [Abstract][Full Text] [Related]
15. [Use of intracranial translucency measurement in first trimester, beyond spina bifida].
Buitrago-Leal M; Molina-Giraldo S
Ginecol Obstet Mex; 2014 Jan; 82(1):20-31. PubMed ID: 24701857
[TBL] [Abstract][Full Text] [Related]
16. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
17. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Aitken DA; Crossley JA
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
[TBL] [Abstract][Full Text] [Related]
18. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cowans NJ; Spencer CE; Achillea N
Prenat Diagn; 2010 Oct; 30(10):937-40. PubMed ID: 20687123
[TBL] [Abstract][Full Text] [Related]
19. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.
Muller F; Benattar C; Audibert F; Roussel N; Dreux S; Cuckle H
Prenat Diagn; 2003 Oct; 23(10):833-6. PubMed ID: 14558029
[TBL] [Abstract][Full Text] [Related]
20. Is there a nuchal translucency threshold above which biochemistry is unnecessary for 1st trimester screening in the Chinese population?
Liao C; Li DZ
J Obstet Gynaecol; 2013 Apr; 33(3):280-1. PubMed ID: 23550858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
